TFE3 and neoplasm with perivascular epithelioid cell differentiation: TFE3-translocated PEComas are less responsive to mTOR inhibitors (21), and the low response rate is associated with MET pathway activation, which is one of the mechanisms of mTOR inhibitor resistance.